Pax6 3′ deletion results in aniridia, autism and mental retardation
- 6 March 2008
- journal article
- case report
- Published by Springer Science and Business Media LLC in Human Genetics
- Vol. 123 (4), 371-378
- https://doi.org/10.1007/s00439-008-0484-x
Abstract
The PAX6 gene is a transcription factor expressed early in development, predominantly in the eye, brain and gut. It is well known that mutations in PAX6 may result in aniridia, Peter’s anomaly and kertatisis. Here, we present mutation analysis of a patient with aniridia, autism and mental retardation. We identified and characterized a 1.3 Mb deletion that disrupts PAX6 transcriptional activity and deletes additional genes expressed in the brain. Our findings provide continued evidence for the role of PAX6 in neural phenotypes associated with aniridia.This publication has 45 references indexed in Scilit:
- Genetic mechanisms underlying abnormal neuronal migration in classical lissencephalyTrends in Genetics, 2007
- Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletionJournal of Medical Genetics, 2007
- Childhood autism and associated comorbiditiesBrain & Development, 2007
- Long-range downstream enhancers are essential for Pax6 expressionDevelopmental Biology, 2006
- A high-resolution survey of deletion polymorphism in the human genomeNature Genetics, 2005
- Polymicrogyria and absence of pineal gland due to PAX6 mutationAnnals of Neurology, 2003
- Missense mutations in the DNA-binding region and termination codon in PAX6Human Mutation, 2003
- PAX6 in sensory developmentHuman Molecular Genetics, 2002
- PAX6 missense mutation in isolated foveal hypoplasiaNature Genetics, 1996
- A high-resolution integrated physical, cytogenetic, and genetic map of human chromosome 11: distal p13 to proximal p15.1Genomics, 1995